Tuesday_talks_thumbnail_NYAS_AI_driven_drug_development

The Science and Business of AI-Driven Drug Discovery   

In this Tuesday Talks  Greg Simon, JD, former Executive Director of the White House Cancer Moonshot Task Force, discusses the future of biotech and healthcare advancement. With a rich background in policy, innovation and patient advocacy, Simon shares insights from his work at the Biden Cancer Initiative and beyond, highlighting transformative strategies that are paving the way for a new era in healthcare.

Healthcare Moonshots: Taking Bold Steps for a Cure

DOJ Healthcare Enforcement: An Insider View

Blue

Insights

Nicole Verbeeck, FTI Senior Director, explores how an innovative mindset can elevate healthcare engagement campaigns for the best stakeholder engagement.   


Cure Tuesday Talks banner image FTI Consulting Nicole Verbeeck

Innovation, Inspiration and Creativity in Healthcare Engagement

Michael Montello, MBA, discusses NASA, AI and pharma’s transition to using big data and modeling to boost the probability of success of new medicines and vaccines.

Cure Tuesday Talks banner image Michael Montello

How GSK is Powering R&D with Data, Digital and Tech

Why Your Vaginal Microbiome Can Influence Your Health Outcomes 

Physician-scientist-executive Judith Absalon, MD, discusses her experience conducting clinical trials during the COVID-19 pandemic and the current environment. 


Cure Tuesday Talks banner image Judith Absalon 

From Pharma’s Front Lines: Infectious Disease, Vaccines and the Future

A fireside conversation with Adrianne Nickerson, MS, CEO and co-founder of Oula Health, a company revolutionizing maternal health.

Cure Tuesday Talks banner image Adrianne Nickerson

How a Startup is Revolutionizing Maternal Care

A conversation with Ed Damiano, PhD, Founder and Executive Chair of the medical device company Beta Bionics.

Cure Tuesday Talks banner image Ed Damiano

A Father Who is Changing the Landscape for Patients with Type 1 Diabetes

Tuesday Talks welcomes Esther Dyson, the founder of Wellville and best-selling author, to Tuesday Talks. Dyson’s vision is to enhance equitable well-being and drive national action in health. Her innovative approach to business focuses on long-term advantages that go beyond immediate healthcare necessities.

Tuesday Talks: The Future of Equitable Health

A fireside chat with Adam Aponte, MD, MSc, FAAP, a pioneer and passionate advocate for providing quality healthcare, services and products for underserved communities.

Cure Tuesday Talks Adam Aponte banner image

Shaping a New Future to Solve Health Inequities

Tuesday Talks takes a dive deep into patient advocacy with Susannah Fox, an author and passionate advocate dedicated to placing patients and caregivers at the heart of healthcare. As a former CTO of the US Department of Health and Human Services, Susannah has profound insights into why patients and caregivers often find themselves lost in a complex healthcare system that can seem impossible to navigate. 

This is a do-not-miss Tuesday Talks.  Watch Tuesday, March 5th, Register Today!

Unlocking the Power of Radical Patient Advocacy

LEXEO Therapeutics CEO Nolan Townsend discusses how LEXEO is working to solve some of the world's most devastating ailments including cardiovascular disease and Alzheimer's. 

Cure Tuesday Talks banner image Nolan Townsend

A Deep Dive Into Gene Therapies of the Future

Greg Moss, Chief Corporate Strategy and Legal Officer at Evommune, discusses the steps of developing a biopharma startup’s business strategy and landscape.

Cure Tuesday Talks banner image Greg Moss 

What Sets Successful Biotech Companies Apart

Mary Woolley, CEO of Research!America, is a passionate advocate for the critical role of science and technology in society, and for 30 years has been an inspiring leader in promoting women in science. 

Cure Tuesday Talks Mary Woolley banner image

How Critical is Research and Technology to the Future - and Women's Role Within It?

Gilan Megeed, MPH, Principal at Deerfield Management, sheds light on the discoveries being made to address often over-looked aspects of women's health and access to care.

Cure Tuesday Talks banner image Gilan Megeed

Why is a Woman’s Health Overlooked?

What is a cure or treatment worth?  Nicholas M. Boulis, MD, a top neurosurgeon who co-founded Brain Trust Bio, joins Tuesday Talks to discuss tackling the impossible:  the science and business of developing treatments for patients with ALS and other CNS diseases.

Tuesday Talks: What is the Cost of a Cure?

Shalabh Gupta, MD, founder and CEO of Unicycive Therapeutics, shares the remarkable story of how he took his biotech startup public with just one employee. Gupta will reveal the pivotal decisions behind this bold move, explore the challenges of scaling a biotech company, and share his insights on why a strong team can be the cornerstone of long-term success in the biotech sector.

tuesday-talks-shalabh-gupta-building-effective-teams

Tuesday Talks: Building Effective Teams - The Key to Your Company's Success

Wandercraft CEO Matthieu Masselin is using robotics technology to create hands-free exoskeltons  propelling patients with spinal cord injuries to stand up and walk again.

Cure Tuesday Talks banner image Matthieu Masselin

Exoskeletons and the Freedom to Walk Again

Victor Dzau, MD, President of the National Academy of Medicine, and Rick A. Bright, PhD, former Director of BARDA USA, discuss the significance of pandemic preparedness and response.

Cure Tuesday Talks Pandemic Preparedness banner image

100 Days Mission for Pandemic Preparedness

Irene Rombel PhD, MBA, the visionary co-founder and CEO of BioCurie and winner of the Cure Xchange Challenge: Health AI for Good. We’ll discuss her career path from professor to investor and now CEO of an early-stage biotech company harnessing Al to transform cell and gene therapy manufacturing.

Pioneering BioCurie's Vision

Viq Pervaaz, MS, Senior Vice President, Life Sciences & Healthcare at the New York City Economic Development Corporation (NYCEDC) discusses how the City is paving the way to become a biotech mecca and a leader in the use of AI for drug discovery. He offers a sneak peek into the NY EDC’s ambitious 2025 goals, from his perspective as leader of the groundbreaking LifeSci NYC, a  more than $1 billion initiative to drive jobs and establish NYC as a global hub for life science innovation.

Viq Pervaaz on Pioneering NYC's Vision for the Future of Life Sciences

Are you fascinated by the intersection of technology, neuroscience and business? Tune in to our Tuesday Talks chat with Nader Halim, PhD, MBA, CEO of Innervace, a resident Cure company. Discover how this regenerative therapy startup is combining business and regenerative therapy to pioneer a new frontier for Parkinson's disease treatment.


Startup Lessons on Rebuilding Brains to Treat Parkinson’s

In this eye-opening Tuesday Talk, take a glimpse into the future with one of the top synthetic biologists in the world. 

Cure Tuesday Talks Christopher Mason banner image

Synthetic Biology, Space and the Next 500 Years

How are genome engineers building a company with new mRNA platforms to develop new therapies for cancers, neurodegenerative disorders, metabolic diseases, and more? Chidiebere Uzodinma Awah, MD, PhD, the CEO and President of UTR Therapeutics Inc. shares his approach to translating cutting-edge science into a successful life science business model.

How to Build a mRNA Company to Combat Cancer

Please join us for Tuesday Talks on October 8th at 12:30pm EDT to watch an insightful conversation with a prominent figure in AI drug discovery. Alex Zhavoronkov, the CEO of Insilico Medicine, will be sharing his latest clinical research findings, discussing upcoming products, and elucidating his company's application of Generative AI in shaping the future of medicine. 

Tuesday Talk Generative AI & The Future of Medicine Headshot

Generative AI & The Future of Medicine

As the guest of Cure's Tuesday Talk, Kevin J. Tracey, MD, president of the Feinstein Institutes at Northwell Health, introduces us to the fascinating world of bioelectronic medicine. Tracey shares his insights into how this innovative approach is reshaping treatment of diseases ranging from cancer to those featuring chronic inflammation. He also shares the Feinstein Institute’s role in enhancing patient care.

Why Bioelectronic Medicine Could Transform Chronic Disease Treatments

Vishal Mehta, MSHS, an expert pharmaceutical innovator, explains how his company speeds one of the most complex and costly enterprises in the life sciences – testing a candidate drug in people.

Cure Tuesday Talks Streamlining Critical Trials header image

Streamlining Clinical Trials 

Tony Boccanfuso, PhD, CEO of UIDP, discusses how his organization helps foster collaboration and partnerships between industry and universities to optimize research outcomes. 

Cure Tuesday Talks banner image Tony Boccanfuso

Understanding the Industry and University Research Relationship

Every three minutes, someone goes to the ER due to food allergies. Related care for food allergies care costs American families $25 billion annually, according to the Food Allergy Fund (FAF). Hear from FAF founder and CEO Ilana Golant, JD, about how this leading nonprofit is funding research to identify underlying causes, discover new therapeutics, and improve the lives of all people living with food allergies.

Cure Tuesday Talks banner image Ilana Golant

The Fight for Food Allergy Cures

Joe Wilson, MBA, Founder and Managing Partner at Undeterred Capital in Los Angeles, talks about the trends in using AI for drug discovery and what investors are looking for in early stage life science companies.

Cure Tuesday Talks Joe Wilson banner image

How Life Science Companies Use AI to Target Investors 

Jessica Federer, MPH, is a globally recognized leader in digital transformation and health technologies. As Cure's Tuesday Talks guest, Federer will discuss the real challenges we still face to narrow the gap in women’s health research. While women make up 51 percent of the U.S. population, their healthcare still lags in respect to technology, policy, and education versus what is offered for men. 

The Real Challenges of Healthcare Research’s Gender Gap

As truth and facts in science are under fire and the media shifts and adjusts to new technologies and expectations, Vice President and Publisher of Scientific American Jeremy Abbate discusses how we need to communicate science in the 21st century. 

Cure Tuesday Talks Jeremy Abbate banner image

Science Communication and Storytelling in the 21st Century

Tuesday-Talks-Peter-Njongwe-june25-thumbnail

A New AI Model to Increase Healthcare Accessibility 

CEO & Co-Founder Maria Luisa Pineda, PhD, of Envisagenics discusses how she brings her passion of culture and diversity to the NYC biopharma community.


Cure Tuesday Talks banner image Maria Luisa Pineda

Exploring Culture and Diversity in BioPharma

Alessandra Henderson, MBA, Co-founder and Board Member of Elektra Health, discusses the gaps in menopause care and how Elektra has been working with insurers to address these challenges. She also covers workplace obstacles, key data insights, investment opportunities in women’s health, and recent legislative advancements in menopause advocacy. 

Menopause: Underfunded, Underserved & Misunderstood

Robert Graham, MD, MPH, aka "Dr. Rob The Chef," shares insights on how healthy eating can help us avoid or even treat serious illnesses. 

Cure Tuesday Talks banner image Dr. Robert Graham 

Can Food Cure Us? 

Rick A. Bright, PhD, shares insights from his career as the former Director of the Biomedical Advanced Research and Development Authority (BARDA), where he working with thousands of health and biomedical companies seeking to develop vaccines and therapies to safe guard public health.

Navigating the Entrepreneurial Ecosystem

The founders of the Clinical Trial Guide discuss the challenges of recruiting patients into studies of investigational treatments.

Cure Tuesday Talks Clinical Trial Guide header image

Clinical Trials and the Challenges Surrounding Patient Access and Recruitment

Lynne Holden, MD, professor of emergency medicine at Albert Einstein College of Medicine, and accomplished entrepreneur Andrew Morrison discuss Mentoring in Medicine’s mission to transform the futures of students hailing from underserved communities in the New York metropolitan area.

Cure Tuesday Talks Changing Lives with Mentoring in Medicine header image 

Changing Lives with Mentoring in Medicine

Cure CEO Seema Kumar sits down with Alex Zhavoronkov, PhD, Chairman and CEO of Insilico Medicine, discussing how generative AI is transforming and accelerating drug discovery.

Cure Tuesday Talks Alex Zhavoronkov banner image

Learning AI for Every Step of Pharma R&D

In this Tuesday Talk, celebrate Pride Month and join the fight against HIV with professionals and advocates dedicated to ending the HIV epidemic.


Cure Tuesday Talks Celebrating Pride Month: The Fight Against HIV thumbnail image 

Celebrating Pride Month: Experts and Allies on the Fight Against HIV

George Vradenburg, the Chairman and co-founder of UsAgainstAlzheimer's, emphasizes the increasing momentum and research dollars being spent in United States and other countries toward finding a cure for Alzheimer's disease. He highlights the collaborative efforts and advancements being made to combat this debilitating disease, with a goal of achieving a breakthrough within the next 10 years. 

tues-talks-one-organizations-fight-cure-alzheimers

Tuesday Talks: One Organization's Fight to Cure Alzheimer's 

Join us for Cure's Tuesday Talk with Rick Weissenstein, Managing Director at TD Cowen will sit down with Cure CEO Seema Kumar to discuss how Election 2024 could influence healthcare policy and investment trends. Gain critical insights into the future of healthcare and explore the potential impact of political decisions on innovation and equity. This is a must-attend event for anyone interested in the intersection of healthcare and policy. Register today! 

Election 2024: Healthcare Policy & Investment Impacts 

Susan Hockfield, PhD, Professor of Neuroscience and President Emerita at MIT, joins Cure CEO Seema Kumar, on the latest episode of Tuesday Talks. They discuss the shared innovation mission of Kendall Square and MIT and its impact on life science entrepreneurship. Hockfield shared insights from her trailblazing leadership of MIT, including strengthening its synergies with Kendall Square’s thriving biotech and tech industries. Discussion includes lessons learned from Hockfield’s projects, like the MIT Energy Initiative, that tackled global challenges and solidified the area as a powerhouse of transformative innovation. 

Cure Tuesday Talks: Susan Hockfield, PhD

On this episode of Tuesday Talks, Cure CEO interviews Carolee Lee, CEO of WHAM, an innovator, entrepreneur, and thought leader dedicated to improving women’s health and investing in women’s health issues. Lee, one of TIME100’s Most Influential People in Global Health, discusses strategies to improve inequities and bias in research while fostering discoveries and economic benefits. 

events_thumbnail_Tuesday_Talks_Carolee_Lee_Breaking_Barriers

Breaking Barriers: Advancing Women’s Health & Innovation

A discussion of the trends in science and inclusion from three leading global figures in communicating science and technology. This special Tuesday Talk was part of the 2023 UN Science Summit, held at Cure. 

Cure Tuesday Talks The Future of Science and Inclusivity thumbnail image

The Future of Science & Inclusivity

Learn about Susan Rosenthal’s journey from the C-Suite to City Hall, the rapid growth of New York City as a biotech and Health IT hub, and what the government can do for your company.  


Cure Tuesday Talks banner image Susan Rosenthal

How Government Helps Drive Healthcare Innovation in NYC

Darshak Sanghavi, MD, is one of the first Program Managers at the Advanced Research Projects Agency for Health (ARPA-H), the new multibillion dollar U.S. agency tasked with developing health programs “so bold no one else, not even the private sector, is willing to give them a chance.” He discusses how this program shines a light on investing in healthcare prevention. 

Cure Tuesday Talks A Bold New Approach to Wellness header image

A Bold New Approach to Wellness

A Pioneer of Biotech Shares Secrets of his Success

Results in at least half of all pubished life science studies cannot be reproduced when researchers try to verify results. Head of Pre-Clinical Pharmacology at Deerfield Discovery & Development, LLC (3DC) Christine Brideau, PhD, describes recent reproducibility studies from Bayer and Amgen—and offers suggestions for narrowing the verification gap.

Cure Tuesday Talks banner image Christine Brideau

The Research Reproducibility Problem and Its Impact on Drug Discovery

Female-founded startups succeed more often but get less than 2 percent of global VC funding. Melissa Wallace from Fierce Foundry joins Tuesday Talks to discuss how a new VC model is helping female entrepreneurs in FemTech thrive from idea to exit.

A Funding Roadmap for Female Entrepreneurs

Xchange Challenge winners and co-founders Grant W. Mitchell MD, MBA, and David Fajgenbaum, MD, MBA, MSc from Every Cure join Tuesday Talks. Learn about their groundbreaking AI-powered platform that offers solutions for rare disease treatments and cures—a capability beyond the reach of many medical experts today. We'll delve into how their $48.3 million government grant will be fueling meaningful advancements, Fajgenbaum's personal victory over his rare disease, and the company's patient-first approach at their new Cure NYC headquarters.


AI & The Future of Cures

The healthcare landscape is dynamic – it’s transforming. Joe Shonkwiler, MD, MBA, the COO of the US government’s Advanced Research Projects Agency for Health joins Tuesday Talks to discuss how the agency is pioneering accessible "moonshot" healthcare solutions that transcend conventional research and commercial efforts. 

An Inside Look at ARPA-H: the US Agency Investing in Revolutionizing Accessible Healthcare Solutions

Daniel Kraft, MD, Founder and Chair of ‪@NextMedHealth‬, discusses what’s Now, Near, and Next in rapidly evolving technologies, from AI, Big Data, and Virtual Reality to Robotics, Synthetic Biology, and Low-Cost Omics. 

Tuesday Talks: What’s Now, Near & Next in Health Tech?

Entrepreneur, investor, and former Genzyme executive Jim Geraghty, JD, MS, discusses how biotech companies can overcome the many hurdles faced in developing treatments for rare and serious diseases.

Cure Tuesday Talks banner image Jim Geraghty 

How to Build a Company and Tackle the Toughest Diseases

Join us for an inspiring Tuesday Talks with Kristen Dahlgren, breast cancer survivor, former Today Show host, and Founder & CEO of the Cancer Vaccine Coalition. We’ll discuss her personal journey from surviving cancer to leading advocacy by working with researchers to effectively bring a breast cancer vaccine to market in 5 to 10 years. 

Empowered - A Journey from Survivor to CEO 

Veteran life sciences investor Gillian Sandler, Managing Partner of Galapont Capital, shares insights into what to invest in, the current market environment, and what drives her to help develop treatments and cures for debilitating diseases.

Cure Tuesday Talks How a Passionate Investor Battles Auto-Immunity header image

How a Passionate Investor Battles Autoimmune Diseases

Recent CDC statistics show maternal mortality rates remain unacceptably high and are exacerbated by racial disparities. Elizabeth Garner, MD, MPH, the Chief Scientific Officer at Ferring Pharmaceuticals US, joins Tuesday Talks to discuss the latest research and the scientific, social and political challenges that must be addressed.

ENOUGH! Addressing the Maternal Health Crisis

From MDs to PhDs to CEOs, Tuesday Talks delved into what investors are seeking to fund while exploring new treatments that are revolutionizing our approach to potential cures in the future. Before our new season begins in September, we invite you to watch the Best of Tuesday Talks on Tuesday, August 20, 2024, at 12:30 pm EDT. 

The Best of Tuesday Talks 

Laura Katz, MA, CEO of Helaina, is working to improve health through food technology. Join this innovative entrepreneur for the next Tuesday  Talks and learn how she’s building a business around bioactive proteins found in human breast milk.

AI-Powered Companies Dominate 2025 Digital Health Funding

Cure’s Landmark Report Reveals 87% of Healthcare Leaders Remain Optimistic About Future, Despite Challenges

Your Home in NYC

November 11 -13 , 2025

Cure Presents: The X Factor Healthcare Innovation Summit

Accelerating Advances in Health

Cure Conversations

Events

Recommended Topics

Join our community